IMPORTANT: UPDATED Guidance for Patients on COVID-19 including Vaccine Information»
Join us for a morning of fun, remembrance, and awareness at our 3rd annual March for Marrow Walk Miami in memory of Jennifer Zighelboim. This year we move to a new walk location - Historic Virginia Key Beach Park! Festivities include a food truck and live music, as well as a day of fun connecting with fellow patients and families affected by
Our 3rd annual March for Marrow 5K Run & Walk DC is in memory of Richard W. Carr and Ivan Fisher. Join us for a morning of fun, remembrance, and awareness at Hains Point! Festivities include team photos, awards, a memorial celebration, music, refreshments, inspirational speakers and a morning of fellowship with patients, families and friends affected by a
Join us for the 8th Annual March for Marrow 5K Run & Walk and help us find a cure for
Chronic graft-versus-host disease (cGVHD) currently represents the leading cause of nonrelapse mortality and morbidity after allogeneic hematopoietic stem cell transplantation (SCT). In parallel with an increased use of
Thank you for attending the 2017 Patient and Family Conference in Orlando, FL.
Thank you for attending the 2017 Patient and Family Conference in Kansas City, MO.
The most common cause of post-transplant mortality in patients with hematological malignancy is relapse, followed by GvHD, infections, organ toxicity and second malignancy. Immune-mediated complications such as GvHD continue to be challenging, yet amenable to control through manipulation of the T-cell compartment of the donor graft with subsequent immunomodulation after transplant. However, risk of both relapse and infection increase concomitantly with T-cell depletion (TCD) strategies that impair immune recovery.
